CD47 and non-Hodgkin lymphoma: Furthermore, circulating tumor cells (CTC) positive for CD47 expression are responsible for tumor relapse and metastasis in breast cancer patients27, while constitutive CD47 upregulation is essential for non-Hodgkin lymphoma immunotolerance and dissemination9.